Lung Tumor Growth Modeling in Patients with NSCLC Undergoing Radiotherapy

被引:3
|
作者
Ghita, Maria [1 ,2 ,3 ]
Chandrashekar, Vasudha [1 ]
Copot, Dana [1 ,2 ]
Billiet, Charlotte [4 ,5 ]
Verellen, Dirk [4 ,5 ]
Ionescu, Clara M. [1 ,2 ,6 ]
机构
[1] Univ Ghent, Res Grp Dynam Syst & Control, B-9052 Ghent, Belgium
[2] Flanders Make Consortium, EEDT Core Lab Decis & Control, B-9052 Ghent, Belgium
[3] Canc Res Inst Ghent, B-9052 Ghent, Belgium
[4] Iridium Canc Network GZA Hosp Sint Augustinus, Dept Radiat Oncol, B-2610 Antwerp, Belgium
[5] Antwerp Univ, Dept Radiotherapy, Fac Med & Hlth Sci, B-2610 Antwerp, Belgium
[6] Tech Univ Cluj Napoca, Dept Automat Control, Cluj Napoca 400114, Romania
来源
IFAC PAPERSONLINE | 2021年 / 54卷 / 15期
关键词
Mathematical modeling; lung cancer; stereotactic body radiation therapy; tumor dynamics; fractional calculus; CANCER;
D O I
10.1016/j.ifacol.2021.10.261
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
This paper proposes two modeling approaches to predict lung tumor dynamics as an effect of radiotherapy. Real clinical information of non-small cell lung cancer (NSCLC) patients undergoing stereotactic body radiation therapy (SBRT) as the primary treatment method has been used for numerical simulations. The classical Gompertz model for tumor volume growth prediction was modified using a fractional parameter and combined with the linear-quadratic model to foresee the effect of SBRT on the targeted tumor. Another approach was implemented by following a pharmacokinetic-pharmacodynamic (PKPD) minimal compartmental model for single therapy with SBRT. Statistical analysis has been carried out to compare the two models. In terms of tumor growth prediction, obtained results indicated a decrease in the total tumor volume for both modeling approaches. A striking observation to emerge from the data comparison is the interesting perspective of fractional tools for further exploration in modeling tumor growth. Copyright (C) 2021 The Authors.
引用
收藏
页码:233 / 238
页数:6
相关论文
共 50 条
  • [21] PET ASSESSMENT OF TUMOR PROLIFERATION, METABOLISM AND HYPOXIA BEFORE AND DURING RADIOTHERAPY IN PATIENTS WITH NON SMALL CELL LUNG CANCER (NSCLC)
    Dubray, B.
    Vera, P.
    Edet-Sanson, A.
    Bohn, P.
    Salles, A.
    Hapdey, S.
    Gardin, I.
    Menard, J.
    Thiberville, L.
    RADIOTHERAPY AND ONCOLOGY, 2010, 94 : S19 - S19
  • [22] Radiobiological Modeling for lung tumor volume regression during the course of radiotherapy
    Guerrero, A.
    Ramsey, C. R.
    Li, X. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S68 - S68
  • [23] Lung tumour vascularity is a risk factor for survival in NSCLC patients undergoing surgery
    Filippi, A. R.
    Blistein, F.
    Belmans, F.
    Goffart, S.
    Libert, L.
    Narasimhan, R.
    Corsi, A.
    Vos, W.
    Occhipinti, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S266 - S266
  • [24] Characterization of human effectors in the tumor microenvironment of NSCLC patients and lung tumor xenograft models
    Ra, Hyun-Jeong
    Brake-Silla, Gisela
    Eruslanov, Evgeniy
    Sharp, Michael
    Deshpande, Charuhas
    Feldman, Michael D.
    Ziober, Amy
    Wang, Li-Ping
    Sepulveda, Manuel A.
    Snyder, Linda A.
    Danet-Desnoyers, Gwenn
    CANCER RESEARCH, 2016, 76
  • [25] Pilot evaluation of cytokine levels in patients undergoing radiotherapy for brain tumor
    Gridley, DS
    Loredo, LN
    Slater, JD
    Archambeau, JO
    Bedros, AA
    Andres, ML
    Slater, JM
    CANCER DETECTION AND PREVENTION, 1998, 22 (01): : 20 - 29
  • [26] ACUTE SECONDARY EFFECTS IN THE ESOPHAGUS IN PATIENTS UNDERGOING RADIOTHERAPY FOR CARCINOMA OF THE LUNG
    MASCARENHAS, F
    SILVESTRE, ME
    DACOSTA, MS
    GRIMA, N
    CAMPOS, C
    CHAVES, P
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (01): : 34 - 40
  • [27] Association of Heart Base Dose With Overall Survival in Patients With NSCLC Undergoing Postoperative Radiotherapy Reply
    McWilliam, Alan
    Abravan, Azadeh
    Banfill, Kathryn
    Faivre-Finn, Corinne
    van Herk, Marcel
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (06) : E64 - E66
  • [28] Radiotherapy affects immunotherapy efficacy based on tumor mutation status in patients with metastatic NSCLC
    Li, S.
    Zhao, Y.
    Manochakian, R.
    Lou, Y.
    ANNALS OF ONCOLOGY, 2023, 34
  • [29] Variation of FDG-PET tumor metabolism during external radiotherapy (ERT) in patients with non small cell lung cancer (NSCLC)
    Edet-Sanson, Agathe
    Doyeux, Kaya
    Dubray, Bernard
    Hapdey, Sebastien
    Hitzel, Anne
    Guernou, Mohamed
    Modezelewski, Romain
    Gensanne, David
    Gardin, Isabelle
    Vera, Pierre
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [30] Expanding Tumor Lymphocytic Infiltration as a Prognostic Tool to Patients with NSCLC Who Are Treated with Radiotherapy?
    Kalbasi, Anusha
    Beatty, Gregory L.
    Berman, Abigail T.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) : E141 - E142